Antiviral resin material, method for producing antiviral resin molded article, and antiviral resin molded article
Patent Information
- Application Number
- JP2023547226
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Filing Date
- 2024-10-08
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Conventional resin molded products with antiviral agents often fail to fully exhibit antiviral properties, requiring high concentrations of antiviral agents, which increases manufacturing costs and may not maintain effectiveness over time.
A thermoplastic resin material containing a polyolefin resin, an antiviral agent such as a sulfonic acid or silver-based agent, and a hydrophilic compound, which enhances antiviral properties by promoting virus adsorption and maintaining effectiveness even with low antiviral agent concentrations.
The combination of thermoplastic resin, antiviral agent, and hydrophilic compound in the resin material significantly enhances antiviral properties, maintaining effectiveness over time and reducing the need for high antiviral agent concentrations, while also improving water, solvent, and alkali resistance.
Abstract
Description
Antiviral resin material, manufacturing method of antiviral resin molded product, and antiviral resin molded product
[0001] The present invention relates to an antiviral resin material containing an antiviral agent. The present invention also relates to a method for producing an antiviral resin molded article, and an antiviral resin molded article.
[0002] In recent years, infectious diseases caused by viruses such as severe acute respiratory syndrome (SARS) virus, avian influenza virus, foot-and-mouth disease virus, new influenza virus, and novel coronavirus have become a social problem.
[0003] For this reason, the use of antiviral molded products on components that are touched by an unspecified number of people or on parts that may be touched by such people is being considered.
[0004] Patent Document 1 below discloses a resin molded article containing a polymer resin, stearyldiethanolamine, and palmityldiethanolamine. In the resin molded article, the content of palmityldiethanolamine is 2 to 25 parts by mass per 100 parts by mass of the total amount of stearyldiethanolamine and palmityldiethanolamine. The polymer resin contains a polyolefin or a polyamide.
[0005] WO2022 / 131331A1
[0006] In conventional resin molded articles such as that described in Patent Document 1, even if an antiviral agent is contained, the antiviral properties of the antiviral agent may not be fully exhibited. In conventional resin molded articles, a large amount of the antiviral agent must be blended in to sufficiently enhance the antiviral properties of the resin molded article, which may increase production costs.
[0007] An object of the present invention is to provide an antiviral resin material that can effectively enhance the antiviral properties of an antiviral agent. Another object of the present invention is to provide a method for producing an antiviral resin molded article that can effectively enhance the antiviral properties of an antiviral agent, and an antiviral resin molded article.
[0008] According to a broad aspect of the present invention, there is provided an antiviral resin material comprising a thermoplastic resin, an antiviral agent, and a compound different from the antiviral agent and having a hydrophilic group, wherein the thermoplastic resin includes a polyolefin resin, an acrylonitrile-butadiene-styrene resin, or a polyvinyl chloride resin, and the antiviral agent includes a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent.
[0009] In a specific aspect of the antiviral resin material according to the present invention, the content of the compound different from the antiviral agent and having a hydrophilic group is 1% by weight or more and 50% by weight or less, based on 100% by weight of the antiviral resin material.
[0010] In a specific aspect of the antiviral resin material according to the present invention, the content of the antiviral agent is 0.5% by weight or more and 10% by weight or less, based on 100% by weight of the antiviral resin material.
[0011] In a specific aspect of the antiviral resin material according to the present invention, the thermoplastic resin includes the polyolefin resin.
[0012] In a specific aspect of the antiviral resin material according to the present invention, the antiviral agent includes the sulfonic acid-based antiviral agent.
[0013] In a specific aspect of the antiviral resin material according to the present invention, the compound that is different from the antiviral agent and has a hydrophilic group includes a polyethylene glycol compound, cellulose, or polyvinylpyrrolidone.
[0014] In a specific aspect of the antiviral resin material according to the present invention, the antiviral resin material is a resin pellet.
[0015] In a specific aspect of the antiviral resin material according to the present invention, the antiviral resin material is a masterbatch.
[0016] In a specific aspect of the antiviral resin material according to the present invention, the antiviral resin material is an injection molding material.
[0017] According to a broad aspect of the present invention, there is provided a method for producing an antiviral resin molded article, comprising a molding step of molding the above-described antiviral resin material to obtain an antiviral resin molded article.
[0018] In a specific aspect of the method for producing an antiviral resin molded product according to the present invention, the method includes a mixing step of mixing the antiviral resin material with another resin material to obtain a mixed resin material containing the antiviral resin material and the other resin material, and the mixed resin material is molded in the molding step.
[0019] According to a broad aspect of the present invention, there is provided an antiviral resin molded article comprising a thermoplastic resin, an antiviral agent, and a compound different from the antiviral agent and having a hydrophilic group, wherein the thermoplastic resin includes a polyolefin resin, an acrylonitrile-butadiene-styrene resin, or a polyvinyl chloride resin, and the antiviral agent includes a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent.
[0020] According to a broad aspect of the present invention, there is provided an antiviral resin molded article comprising a thermoplastic resin and an antiviral agent, wherein the thermoplastic resin includes a polyolefin resin, an acrylonitrile-butadiene-styrene resin, or a polyvinyl chloride resin, the antiviral agent includes a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent, and the contact angle of the surface of the antiviral resin molded article with water at 23°C is 89° or less.
[0021] In a specific aspect of the antiviral resin molded article according to the present invention, the content of the compound different from the antiviral agent and having a hydrophilic group is 1% by weight or more and 25% by weight or less, relative to 100% by weight of the antiviral resin molded article.
[0022] In a specific aspect of the antiviral resin molded article according to the present invention, the content of the antiviral agent is 0.5% by weight or more and 5% by weight or less, based on 100% by weight of the antiviral resin molded article.
[0023] The antiviral resin material according to the present invention contains a thermoplastic resin, an antiviral agent, and a compound that is different from the antiviral agent and has a hydrophilic group. In the antiviral resin material according to the present invention, the thermoplastic resin includes a polyolefin resin, an acrylonitrile-butadiene-styrene resin, or a polyvinyl chloride resin, and the antiviral agent includes a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent. Because the antiviral resin material according to the present invention has the above configuration, it is possible to effectively enhance the antiviral properties of the antiviral agent.
[0024] The antiviral resin molded article according to the present invention contains a thermoplastic resin, an antiviral agent, and a compound different from the antiviral agent and having a hydrophilic group. In the antiviral resin molded article according to the present invention, the thermoplastic resin includes a polyolefin resin, an acrylonitrile-butadiene-styrene resin, or a polyvinyl chloride resin, and the antiviral agent includes a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent. Because the antiviral resin molded article according to the present invention has the above configuration, the antiviral properties of the antiviral agent can be effectively enhanced.
[0025] The antiviral resin molded article according to the present invention contains a thermoplastic resin and an antiviral agent. In the antiviral resin molded article according to the present invention, the thermoplastic resin contains a polyolefin resin, an acrylonitrile-butadiene-styrene resin, or a polyvinyl chloride resin, and the antiviral agent contains a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent. The contact angle of the surface of the antiviral resin molded article according to the present invention with water at 23°C is 89° or less. Because the antiviral resin molded article according to the present invention has the above configuration, the antiviral properties of the antiviral agent can be effectively enhanced.
[0026] FIG. 1 is a cross-sectional view schematically showing an antiviral resin molded article according to one embodiment of the present invention.
[0027] The present invention will be described in detail below. In the following description, an "antiviral resin material" may be referred to as a "resin material." An "antiviral resin molded product" may be referred to as a "resin molded product." An "acrylonitrile butadiene styrene resin" may be referred to as an "ABS resin." A "compound that is different from an antiviral agent and has a hydrophilic group" may be referred to as a "hydrophilic compound."
[0028] (Resin Material) The resin material according to the present invention contains a thermoplastic resin, an antiviral agent, and a hydrophilic compound. In the resin material according to the present invention, the thermoplastic resin includes a polyolefin resin, an ABS resin, or a polyvinyl chloride resin, and the antiviral agent includes a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent.
[0029] The resin material according to the present invention has the above-described configuration, and therefore can effectively enhance the antiviral properties of the antiviral agent. Furthermore, the resin material according to the present invention can maintain high antiviral properties over a long period of time, even when the resin material or a resin molded product using the same is used for a long period of time. Furthermore, the resin material according to the present invention exhibits high antiviral properties even when the content of the antiviral agent is small, so the amount of antiviral agent used can be relatively small, and costs can be reduced.
[0030] The mechanism by which the above-described effects are exhibited is not particularly limited, but the following reasons are thought to be the reason. In the present invention, the resin material having a specific composition containing the above-described specific thermoplastic resin and the above-described specific antiviral agent further contains the above-described hydrophilic compound. It is thought that this combination of three specific components, particularly due to the above-described hydrophilic compound, allows the antiviral agent, whose inactivation mechanism is virus adsorption, to be present in a good manner on the surface of the resin material or a resin molded article using the same. Furthermore, it is thought that the above-described hydrophilic compound changes the balance between hydrophilicity and hydrophobicity of the surface of the resin material or resin molded article, thereby allowing viruses to migrate and diffuse well to the surface of the resin material or resin molded article.
[0031] Furthermore, since the resin material according to the present invention has the above-described configuration, the water resistance of the resin material or a resin molded product using the same can be improved, and even if the resin material or a resin molded product using the same comes into contact with water, the resin material or the resin molded product can maintain high antiviral properties.
[0032] Furthermore, since the resin material according to the present invention has the above-described configuration, the solvent resistance, particularly ethanol resistance, of the resin material or a resin molded product using the same can be improved, and even if the resin material or a resin molded product using the same comes into contact with a solvent, the resin material or the resin molded product can maintain high antiviral properties.
[0033] Furthermore, since the resin material according to the present invention has the above-described configuration, the alkali resistance, particularly sodium hypochlorite resistance, of the resin material or a resin molded product using the same can be improved.Even if the resin material or a resin molded product using the same comes into contact with an alkaline agent, the resin material or the resin molded product can maintain high antiviral properties.
[0034] For example, the surface of the resin molded article may be wiped with a wiping member containing water, a solvent (ethanol, etc.), or an alkaline agent (sodium hypochlorite, etc.) during cleaning. In the present invention, even if the surface of the resin molded article is wiped, the antiviral properties of the resin molded article are unlikely to change, and durability can be increased.
[0035] (Resin molded article) The resin molded article according to the present invention contains a thermoplastic resin, an antiviral agent, and a hydrophilic compound. In the resin molded article according to the present invention, the thermoplastic resin includes a polyolefin resin, an ABS resin, or a polyvinyl chloride resin, and the antiviral agent includes a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent.
[0036] The resin molded article according to the present invention contains a thermoplastic resin and an antiviral agent. In the resin molded article according to the present invention, the thermoplastic resin includes a polyolefin resin, an ABS resin, or a polyvinyl chloride resin, and the antiviral agent includes a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent. The contact angle of the surface of the resin molded article according to the present invention with water at 23°C is 89° or less.
[0037] The antiviral resin molded article according to the present invention has the above-described configuration, and therefore can effectively enhance the antiviral properties of the antiviral agent. In particular, by using the hydrophilic compound or by setting the contact angle on the surface of the resin molded article to the above-described upper limit or less, the antiviral properties of the antiviral agent can be effectively enhanced. Furthermore, the resin molded article according to the present invention can maintain high antiviral properties over a long period of time, even when the resin molded article is used for a long period of time. Furthermore, the resin molded article according to the present invention exhibits high antiviral properties even with a small content of antiviral agent, so the amount of antiviral agent used can be relatively reduced, thereby reducing costs.
[0038] The mechanism by which the above-described effect is exhibited is not particularly limited, but the following reasons are thought to be the reasons. In the present invention, a resin molded article having a specific composition containing the above-described specific thermoplastic resin and the above-described specific antiviral agent further contains the above-described hydrophilic compound, or the contact angle is controlled to be equal to or less than the above-described upper limit. It is believed that the combination of these three specific components or the combination of these two specific components with the specific contact angle, particularly due to the above-described hydrophilic compound or the specific contact angle, allows the antiviral agent, whose inactivation mechanism is virus adsorption, to be favorably present on the surface of the resin molded article. Furthermore, it is thought that the balance between hydrophilicity and hydrophobicity on the surface of the resin molded article is changed by the above-described hydrophilic compound or the above-described contact angle, thereby allowing viruses to migrate and diffuse favorably to the surface of the resin molded article.
[0039] Furthermore, since the resin molded article according to the present invention has the above-described configuration, it is possible to improve water resistance, and even if the resin molded article comes into contact with water, it is possible to maintain high antiviral properties.
[0040] Furthermore, since the resin molded article according to the present invention has the above-described configuration, it is possible to improve solvent resistance, particularly ethanol resistance, and even if the resin molded article comes into contact with a solvent, it is possible to maintain high antiviral properties.
[0041] Furthermore, since the resin molded article according to the present invention has the above-described configuration, it is possible to improve alkali resistance, particularly resistance to sodium hypochlorite, and the resin molded article can maintain its antiviral properties even when it comes into contact with an alkaline agent.
[0042] For example, the surface of the resin molded article may be wiped with a wiping member containing water, a solvent (ethanol, etc.), or an alkaline agent (sodium hypochlorite, etc.) during cleaning. In the present invention, even if the surface of the resin molded article is wiped, the antiviral properties of the resin molded article are unlikely to change, and durability can be increased.
[0043] The contact angle of the surface of the resin molded article with water at 23°C is preferably 89° or less, more preferably 80° or less, and even more preferably 75° or less. When the contact angle is within the above upper limit, the antiviral properties of the resin molded article are further improved. The contact angle of the surface of the resin molded article with water at 23°C may be 70° or less, less than 70°, 67° or less, or 65° or less. There is no particular limitation on the lower limit of the contact angle. The contact angle of the surface of the resin molded article with water at 23°C may be 30° or more, or 40° or more. The contact angle is preferably measured on the flat surface of the resin molded article.
[0044] Specifically, the contact angle can be measured as follows.
[0045] Using a resin molded article and a contact angle meter (for example, a solid-liquid interface analysis system DropMaster DMs-401 manufactured by Kyowa Interface Science Co., Ltd.), the change in the contact angle with water over time is observed by the sessile drop method. The contact angle is measured 5 minutes after a water droplet lands on the resin molded article. It is preferable to cut the resin molded article into a piece measuring 3 cm long x 3 cm wide and measure the contact angle.
[0046] Examples of methods for reducing the water contact angle of the surface of the resin molded article to the upper limit or less include a method of incorporating a compound (hydrophilic compound) that is different from the antiviral agent and has a hydrophilic group, and a method of hydrophilizing the surface of the resin molded article. By using the hydrophilizing method of the surface of the resin molded article, the effects of the present invention can be achieved without incorporating the hydrophilic compound into the resin material used to obtain the resin molded article. From the viewpoint of more effectively achieving the effects of the present invention, particularly the antiviral properties, the method of using the hydrophilic compound is preferred over the method of using the hydrophilic compound and the method of reducing the contact angle to the upper limit or less. It is more preferable to employ both the method of using the hydrophilic compound and the method of reducing the contact angle to the upper limit or less. Furthermore, using the hydrophilic compound makes it easy to reduce the contact angle to the upper limit or less.
[0047] Other details of the resin material according to the present invention and the resin molded article according to the present invention will be described below.
[0048] [Thermoplastic Resin] Known thermoplastic resins include polyolefin resin, polyvinyl chloride resin, polyamide resin, polycarbonate resin, polystyrene resin, polyester resin, acrylonitrile-butadiene-styrene resin (ABS resin), polyethylene terephthalate (PET), and polymethyl methacrylate (PMMA).
[0049] The resin material and the resin molded product contain a polyolefin resin, an ABS resin, or a polyvinyl chloride resin as a thermoplastic resin. That is, in the present invention, a specific thermoplastic resin is selected and used. The thermoplastic resin may be used alone or in combination of two or more.
[0050] The thermoplastic resin may include a polyolefin resin or an ABS resin, may include a polyolefin resin or a polyvinyl chloride resin, may include an ABS resin or a polyvinyl chloride resin, may include a polyolefin resin, may include an ABS resin, or may include a polyvinyl chloride resin.
[0051] From the viewpoint of more effectively exhibiting the above-described effects of the configuration of the present invention, particularly the antiviral property, the thermoplastic resin preferably contains a polyolefin resin, and more preferably is a polyolefin resin.
[0052] Examples of the polyolefin resin include polyethylene, polypropylene, ethylene-propylene copolymer (EPDM), isobutylene-isoprene copolymer, polystyrene, polybutene, polyisobutylene, polybutadiene, acrylonitrile-butadiene copolymer, ethylene-vinyl acetate copolymer, and ethylene-α-olefin copolymer. Polyethylene is obtained by using 50% by weight or more of ethylene as a polymerization component. Polypropylene is obtained by using 50% by weight or more of propylene as a polymerization component. The polyolefin resins may be used alone or in combination of two or more.
[0053] From the viewpoint of more effectively exerting the above-described effects of the present invention, particularly the antiviral properties, the polyolefin resin is preferably polyethylene or polypropylene, and more preferably polypropylene. From the viewpoint of more effectively exerting the above-described effects of the present invention, particularly the antiviral properties, the thermoplastic resin is preferably polyethylene or polypropylene, and more preferably polypropylene.
[0054] Examples of the polyvinyl chloride resin include a homopolymer of vinyl chloride monomer and a copolymer of vinyl chloride monomer and a vinyl monomer copolymerizable with vinyl chloride. The copolymer is preferably a copolymer of 50% by weight or more of vinyl chloride monomer and 50% by weight or less of a vinyl monomer copolymerizable with vinyl chloride. The polyvinyl chloride resin may be used alone or in combination of two or more types.
[0055] Examples of vinyl monomers copolymerizable with the vinyl chloride monomer include vinyl acetate, acrylonitrile, vinylidene chloride, ethylene, vinyl ether, maleic acid, maleic anhydride, acrylic ester, vinyl fluoride, maleimide, etc. The vinyl monomers may be used alone or in combination of two or more.
[0056] The degree of polymerization of the thermoplastic resin is preferably 10,000 or more, more preferably 100,000 or more. The upper limit of the degree of polymerization of the thermoplastic resin is not particularly limited. The degree of polymerization of the thermoplastic resin is 1×10 100 It may be 1×10 or less, 10 It may be 1×10 or less, 8 It may be the following:
[0057] [Antiviral Agents] Examples of antiviral agents include inorganic antiviral agents and organic antiviral agents. Known examples of the inorganic antiviral agents include metal antiviral agents, such as silver-based and copper-based agents. Known examples of the organic antiviral agents include anionic organic antiviral agents, such as sulfonic acid-based and carboxylic acid-based agents, and cationic organic antiviral agents, such as amine-based agents. Examples of carboxylic acid-based antiviral agents include acrylic acid-based antiviral agents. Examples of amine-based antiviral agents include cationic organic antiviral agents, such as guanidine-based agents.
[0058] The resin material and the resin molded article contain a sulfonic acid antiviral agent, a silver antiviral agent, or a carboxylic acid antiviral agent as an antiviral agent. That is, in the present invention, a specific antiviral agent is selected and used. The antiviral agent may be used alone or in combination of two or more types.
[0059] The antiviral agent may include a sulfonic acid antiviral agent or a silver-based antiviral agent, or may include a sulfonic acid antiviral agent or a carboxylic acid antiviral agent, or may include a silver-based antiviral agent or a carboxylic acid antiviral agent.The antiviral agent may include a sulfonic acid antiviral agent, a silver-based antiviral agent, or a carboxylic acid antiviral agent.
[0060] From the viewpoint of more effectively exhibiting the above-described effects, particularly antiviral property, of the configuration of the present invention, the antiviral agent preferably includes an organic antiviral agent, more preferably includes a sulfonic acid antiviral agent, and further preferably is a sulfonic acid antiviral agent.
[0061] The sulfonic acid antiviral agent includes a compound having a sulfonic acid group or a sulfonate salt. Examples of the sulfonic acid antiviral agent include sulfonic acid group-containing polymer particles and sulfonate-containing polymer particles. The sulfonic acid antiviral agent may be used alone or in combination of two or more.
[0062] Examples of monomers constituting the sulfonic acid antiviral agent (sulfonic acid group-containing polymer particles or sulfonate-containing polymer particles) include sodium styrenesulfonate, calcium styrenesulfonate, ammonium styrenesulfonate, magnesium styrenesulfonate, etc. Only one type of the above monomers may be used, or two or more types may be used in combination.
[0063] The sulfonic acid antiviral agent is preferably a copolymer particle of styrenesulfonic acid or a salt thereof with a hydrophobic monomer, which can effectively prevent whitening of the resin material and the resin molded article when they come into contact with water.
[0064] Examples of the hydrophobic monomer include ethylene, propylene, butylene, butadiene, diisobutylene, vinyl chloride, vinylidene chloride, 2-vinylnaphthalene, styrene, vinyl alkyl ether, vinyl acetate, acrylonitrile, alkyl (meth)acrylate, (meth)acrylic acid, sodium (meth)acrylate, maleic acid, fumaric acid, maleic anhydride, (meth)acrylamide, diacetone acrylamide, vinyl toluene, xylene sulfonic acid, vinyl pyridine, vinyl sulfonic acid, vinyl alcohol, methyl (meth)acrylate, and hydroxyethyl (meth)acrylate. One type of the hydrophobic monomer may be used alone, or two or more types may be used in combination.
[0065] From the viewpoint of more effectively suppressing whitening of the resin material and the resin molded article, the hydrophobic monomer is preferably styrene or 2-vinylnaphthalene, and more preferably styrene.
[0066] Examples of copolymer particles of styrene sulfonic acid or a salt thereof with styrene include styrene sulfonic acid-styrene copolymer particles, styrene sulfonate-styrene copolymer particles, and styrene sulfonate-styrene sulfonic acid-styrene terpolymer particles.
[0067] Examples of the styrene sulfonate-styrene copolymer particles include sodium styrene sulfonate-styrene copolymer particles, calcium styrene sulfonate-styrene copolymer particles, ammonium styrene sulfonate-styrene copolymer particles, magnesium styrene sulfonate-styrene copolymer particles, etc. The styrene sulfonate-styrene copolymer particles are preferably sodium styrene sulfonate-styrene copolymer particles, and more preferably sodium p-styrene sulfonate-styrene copolymer particles.
[0068] Examples of the styrene sulfonate-styrene sulfonic acid-styrene terpolymer particles include sodium styrene sulfonate-styrene sulfonic acid-styrene terpolymer particles, calcium styrene sulfonate-styrene sulfonic acid-styrene terpolymer particles, ammonium styrene sulfonate-styrene sulfonic acid-styrene terpolymer particles, and magnesium styrene sulfonate-styrene sulfonic acid-styrene terpolymer particles. The styrene sulfonate-styrene sulfonic acid-styrene terpolymer particles are preferably sodium styrene sulfonate-styrene sulfonic acid-styrene terpolymer particles, and more preferably p-sodium styrene sulfonate-styrene sulfonic acid-styrene terpolymer particles.
[0069] The weight-average molecular weight of the polymer constituting the sulfonic acid antiviral agent is preferably 20,000 or more, more preferably 50,000 or more, even more preferably 100,000 or more, and preferably 1,000,000 or less. When the weight-average molecular weight of the polymer is equal to or greater than the lower limit, the antiviral properties can be more effectively exhibited. When the weight-average molecular weight of the polymer is equal to or less than the upper limit, the viscosity of the resin material can be set within an appropriate range, and the resin material can be easily handled.
[0070] When the sulfonic acid antiviral agent is used in combination with a compound having a carbonyl group or an ether group, the sulfonic acid group, which is a polar group, becomes compatible with the carbonyl group or ether group, which tends to reduce the antiviral activity of the antiviral agent. Therefore, when the sulfonic acid antiviral agent is used in combination with a compound having a carbonyl group or an ether group, it is preferable to use a copolymer of polymerization components containing a monomer with low polarity (low-polarity monomer) as the sulfonic acid antiviral agent.
[0071] Examples of the low polarity monomer include compounds having a (meth)acryloyl group, etc. The (meth)acryloyl group means an acryloyl group or a methacryloyl group.
[0072] Examples of the compound having a (meth)acryloyl group include ethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, 1,9-nonanediol dimethacrylate, neopentyl glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, hydroxypivalic acid neopentyl glycol di(meth)acrylate, dicyclopentanyl di(meth)acrylate, caprolactone-modified dicyclopentenyl di(meth)acrylate, ethylene oxide-modified phosphate di(meth)acrylate, allylated cyclohexyl di(meth)acrylate, and isocyanurate di(meth)acrylate. , trimethylolpropane tri(meth)acrylate, ethylene oxide-modified trimethylolpropane tri(meth)acrylate, dipentaerythritol tri(meth)acrylate, propionic acid-modified dipentaerythritol tri(meth)acrylate, pentaerythritol tri(meth)acrylate, propylene oxide-modified trimethylolpropane tri(meth)acrylate, tris(acryloxyethyl)isocyanurate, propionic acid-modified dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, ethylene oxide-modified dipentaerythritol hexa(meth)acrylate, and caprolactone-modified dipentaerythritol hexa(meth)acrylate.
[0073] The compound having a (meth)acryloyl group is preferably polyethylene glycol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, or dipentaerythritol hexa(meth)acrylate.
[0074] The silver-based antiviral agent contains silver or a salt thereof. The silver-based antiviral agent is, for example, silver-containing particles. The silver-based antiviral agent (silver-containing particles) may be used alone or in combination of two or more types.
[0075] The silver-based antiviral agent (silver-containing particles) includes silver particles, silver salt particles, and silver complex particles. Examples of the silver salt include silver nitrate, silver sulfate, and silver chloride. Examples of the silver complex include silver thiosulfite complex and silver sodium chloride complex.
[0076] The silver-based antiviral agent (silver-containing particles) also includes particles in which a silver-containing compound is supported on a carrier. Examples of the silver-containing compound include silver particles, silver salt particles, and silver complex particles. Examples of the carrier include zeolite, silica gel, silicate, phosphate, soluble glass, activated carbon, and metal carriers.
[0077] Further examples of the silver-based antiviral agent (silver-containing particles) include colloidal silver, which has an average particle size of, for example, 1 nm or more and 1 μm or less.
[0078] The carboxylic acid antiviral agent includes a compound derived from a carboxylic acid or a carboxylate. The carboxylic acid antiviral agent may be used alone or in combination of two or more.
[0079] The carboxylic acid antiviral agent preferably has at least one carboxyl group. Examples of the carboxylic acid antiviral agents include compounds derived from adipic acid, benzoic acid, lauric acid, azelaic acid, sebacic acid, dodecanedioic acid, fumaric acid, phthalic acid, isophthalic acid, terephthalic acid, methylenedisalicylic acid, cis-Δ4-tetrahydrophthalic acid, caproic acid, enanthic acid, caprylic acid, pelargonic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, myristoleic acid, oleic acid, ricinoleic acid, salicylic acid, gallic acid hydrate, benzilic acid, 4-aminobenzoic acid, triglycolaminic acid, ethylenediaminetetraacetic acid, 1,3-diaminopropanetetraacetic acid, ethylenediaminesuccinic acid, diethylenetriaminepentaacetic acid, 1-amino-1-cyclobutanecarboxylic acid, cycloleucine, 1-aminocyclohexanecarboxylic acid, 3-aminocyclohexanecarboxylic acid, and acrylic acid.
[0080] Examples of the compound derived from acrylic acid include an acrylic acid-methyl (meth)acrylate copolymer, an acrylic acid-ethyl (meth)acrylate copolymer, an acrylic acid-butyl (meth)acrylate copolymer, an acrylic acid-2-ethylhexyl (meth)acrylate copolymer, and an acrylic acid-(methacrylic acid) copolymer.
[0081] From the viewpoint of more effectively exerting the above-described effects of the configuration of the present invention, particularly the antiviral properties, it is preferable that the thermoplastic resin contains a polyolefin resin and the antiviral agent contains a sulfonic acid-based antiviral agent, and it is more preferable that the thermoplastic resin is a polyolefin resin and the antiviral agent is a sulfonic acid-based antiviral agent. That is, as a combination of the thermoplastic resin and the antiviral agent, a combination of a polyolefin resin and a sulfonic acid-based antiviral agent is particularly preferable. By further adding the hydrophilic compound to this specific combination composition, the antiviral properties are significantly improved.
[0082] From the viewpoint of more effectively exerting the above-described effects of the configuration of the present invention, particularly antiviral properties, the antiviral agent is preferably an antiviral agent in which a surfactant is carried on organic particles. In the following description, "an antiviral agent in which a surfactant is carried on organic particles" may be referred to as "antiviral agent X." The antiviral agent X is a particle.
[0083] Examples of materials for the organic particles include resins, etc. The organic particles are preferably resin particles.
[0084] The resin constituting the organic particles (or resin particles) may be a thermoplastic resin or a cured product of a thermosetting resin. When the resin constituting the organic particles in the antiviral agent X is a thermoplastic resin, the thermoplastic resin constituting the organic particles is not included in the thermoplastic resin contained in the resin material. The thermoplastic resin constituting the organic particles is different from the thermoplastic resin contained in the resin material.
[0085] Examples of the resin constituting the organic particles include polypropylene (PP) resin, polyvinyl chloride (PVC) resin, polymethyl methacrylate (PMMA) resin, polystyrene (PS) resin, polycarbonate resin, polyethylene terephthalate (PET) resin, aromatic polyester resin, acrylonitrile butadiene styrene (ABS) resin, acrylonitrile styrene (AS) resin, methyl methacrylate styrene (MS) resin, methyl methacrylate butadiene styrene (MBS) resin, epoxy resin, polyurethane resin, polyethylene (PE) resin, polyether ether ketone (PEEK) resin, polyether ketone ketone (PEKK) resin, thermoplastic olefin (TPO) resin, polytetrafluoroethylene resin, polyvinyl fluoride (PVF) resin, and silicone resin.
[0086] Examples of the surfactant include anionic surfactants and cationic surfactants. The surfactants may be used alone or in combination of two or more.
[0087] From the viewpoint of more effectively exhibiting the above-described effects of the configuration of the present invention, particularly the antiviral property, the surfactant is preferably a sulfonic acid surfactant. The sulfonic acid antiviral agent is preferably an antiviral agent in which a sulfonic acid surfactant is supported on organic particles.
[0088] Examples of the sulfonic acid surfactant include alkylbenzene sulfonic acid compounds, alkyl diphenyl ether disulfonic acid compounds, alkyl naphthalene sulfonic acid compounds, alkyl sulfate ester compounds, polyoxyethylene alkyl sulfate ester compounds, and naphthalene sulfonic acid formalin condensate compounds, etc. The sulfonic acid surfactant may be used alone or in combination of two or more.
[0089] From the viewpoint of more effectively exerting the above-described effects of the configuration of the present invention, particularly the antiviral activity, the sulfonic acid surfactant is preferably an alkylbenzenesulfonic acid compound, an alkyldiphenyletherdisulfonic acid compound, or an alkylnaphthalenesulfonic acid compound.
[0090] In the antiviral agent X, the content of the surfactant per 100 parts by weight of the organic particles (the amount of the surfactant supported per 100 parts by weight of the organic particles) is preferably 20 parts by weight or more, more preferably 30 parts by weight or more, and preferably 50 parts by weight or less, and more preferably 40 parts by weight or less. When the content of the surfactant is equal to or more than the above-mentioned lower limit and equal to or less than the above-mentioned upper limit, the effects of the configuration of the present invention, in particular the antiviral property, can be exhibited more effectively.
[0091] The particle size of the antiviral agent (such as the antiviral agent X) is preferably 0.1 μm or more, more preferably 0.5 μm or more, even more preferably 1 μm or more, and is preferably 50 μm or less, more preferably 20 μm or less, even more preferably 10 μm or less, and particularly preferably 5 μm or less. When the particle size of the antiviral agent is at least the above-mentioned lower limit, the antiviral agent is less likely to aggregate in the resin material or resin molded article, and the dispersibility of the antiviral agent can be increased, thereby improving the appearance of the resin material or resin molded article. When the particle size of the antiviral agent is at most the above-mentioned upper limit, the appearance of the resin material or resin molded article can be further improved.
[0092] The particle size of the antiviral agent is preferably the average particle size of the entire antiviral agent. The average particle size of the antiviral agent is preferably the number average particle size. The average particle size of the antiviral agent can be determined, for example, by dispersing the antiviral agent in a solvent such as squalane and performing laser diffraction particle size distribution measurement.
[0093] [Compound different from antiviral agents and having a hydrophilic group (hydrophilic compound)] The resin material contains the hydrophilic compound. The resin molded article preferably contains the hydrophilic compound. When the contact angle on the surface of the resin molded article is equal to or less than the upper limit, the resin molded article may or may not contain the hydrophilic compound. The hydrophilic compound is different from a thermoplastic resin. Only one type of the hydrophilic compound may be used, or two or more types may be used in combination.
[0094] Examples of the hydrophilic group include an ether group, a hydroxy group, a carboxy group, an amino group, an amide group, etc. From the viewpoint of more effectively exhibiting the effects of the present invention, particularly the antiviral properties, the hydrophilic group is preferably an ether group, a hydroxy group, or an amide group.
[0095] Examples of the hydrophilic compound include polyethylene glycol-based compounds, cellulose, and polyvinylpyrrolidone. Examples of the polyethylene glycol-based compounds include polyethylene glycol and polyethylene glycol fatty acid esters. From the viewpoint of more effectively exhibiting the above-mentioned effects of the configuration of the present invention, particularly antiviral properties, the hydrophilic compound preferably includes a polyethylene glycol-based compound, cellulose, or polyvinylpyrrolidone, more preferably includes a polyethylene glycol-based compound or polyvinylpyrrolidone, even more preferably includes polyethylene glycol, polyethylene glycol fatty acid ester, or polyvinylpyrrolidone, and particularly preferably includes polyvinylpyrrolidone. Polyvinylpyrrolidone has an amide group as a hydrophilic group. The polyethylene glycol-based compound, cellulose, and polyvinylpyrrolidone may each have a structure other than the hydrophilic group.
[0096] [Other Components] The resin material may contain other components such as a solvent, a thickener, a filler, an antibacterial agent, a flame retardant, an antifungal agent, an ultraviolet absorber, and a tackifier. Only one of the other components may be used, or two or more of them may be used in combination.
[0097] [Amount of each component in the resin material] The content of the thermoplastic resin in 100% by weight of the resin material is preferably 40% by weight or more, more preferably 45% by weight or more, even more preferably 50% by weight or more, particularly preferably 55% by weight or more, and preferably 99.8% by weight or less, more preferably 97% by weight or less, even more preferably 96% by weight or less, even more preferably 95% by weight or less, even more preferably 90% by weight or less, particularly preferably 85% by weight or less, and most preferably 80% by weight or less. When the content of the thermoplastic resin is above the lower limit, the moldability of the resin material and the dispersibility of the components are further improved. When the content of the thermoplastic resin is below the upper limit, the moldability and mechanical properties of the resin material and the resin molded product using it are further improved.
[0098] The content of the antiviral agent in 100% by weight of the resin material is preferably 0.1% by weight or more, more preferably 0.5% by weight or more, even more preferably 1% by weight or more, particularly preferably 2% by weight or more, and most preferably 3% by weight or more, and is preferably 20% by weight or less, more preferably 10% by weight or less, even more preferably 8% by weight or less, particularly preferably 6% by weight or less, and most preferably 5% by weight or less. When the content of the antiviral agent is above the lower limit, the antiviral properties of the resin material and resin molded products using it are further improved. When the content of the antiviral agent is below the upper limit, the moldability and mechanical properties of the resin material and resin molded products using it are further improved.
[0099] The content of the hydrophilic compound in 100% by weight of the resin material is preferably 0.1% by weight or more, more preferably 0.5% by weight or more, even more preferably 1% by weight or more, particularly preferably 2% by weight or more, and most preferably 5% by weight or more, and is preferably 70% by weight or less, more preferably 50% by weight or less, even more preferably 30% by weight or less, particularly preferably 20% by weight or less, and most preferably 10% by weight or less. When the content of the hydrophilic compound is above the lower limit, the antiviral properties of the resin material and resin molded products using it are further improved. When the content of the hydrophilic compound is below the upper limit, the moldability and mechanical properties of the resin material and resin molded products using it are further improved.
[0100] The total content of the antiviral agent and the hydrophilic compound in 100% by weight of the resin material is preferably 0.2% by weight or more, more preferably 0.5% by weight or more, even more preferably 0.8% by weight or more, particularly preferably 1.5% by weight or more, and most preferably 3% by weight or more, and is preferably 80% by weight or less, more preferably 60% by weight or less, even more preferably 40% by weight or less, particularly preferably 30% by weight or less, and most preferably 11% by weight or less. When the total content of the antiviral agent and the hydrophilic compound is above the lower limit, the antiviral properties of the resin material and resin molded articles using the same are further improved. When the total content of the antiviral agent and the hydrophilic compound is below the upper limit, the moldability and mechanical properties of the resin material and resin molded articles using the same are further improved.
[0101] In the resin material, the weight ratio of the content of the antiviral agent to the content of the hydrophilic compound is referred to as the weight ratio (antiviral agent content / hydrophilic compound content). The weight ratio (antiviral agent content / hydrophilic compound content) is preferably 0.1 or more, more preferably 0.15 or more, even more preferably 0.2 or more, and particularly preferably 0.25 or more, and is preferably 10 or less, more preferably 5 or less, even more preferably 1 or less, even more preferably 0.8 or less, particularly preferably 0.5 or less, and most preferably 0.4 or less. When the weight ratio (antiviral agent content / hydrophilic compound content) is equal to or greater than the lower limit and equal to or less than the upper limit, the antiviral properties of the resin material and the resin molded product using the same are further improved.
[0102] The total content of the thermoplastic resin, the antiviral agent, and the hydrophilic compound in 100% by weight of the resin material is preferably 50% by weight or more, more preferably 70% by weight or more, even more preferably 80% by weight or more, and particularly preferably 90% by weight or more. The total content of the thermoplastic resin, the antiviral agent, and the hydrophilic compound in 100% by weight of the resin material may be 100% by weight, 100% by weight or less, or even less than 100% by weight. When the total content of the thermoplastic resin, the antiviral agent, and the hydrophilic compound is equal to or greater than the lower limit, the antiviral properties of the resin material and the resin molded product using the same are further improved.
[0103] [Amount of each component in the resin molded article] The content of the thermoplastic resin in 100% by weight of the resin molded article is preferably 50% by weight or more, more preferably 60% by weight or more, even more preferably 70% by weight or more, particularly preferably 80% by weight or more, and preferably 99.8% by weight or less, more preferably 97% by weight or less, even more preferably 96% by weight or less, particularly preferably 95% by weight or less. When the content of the thermoplastic resin is above the lower limit, the moldability and mechanical properties of the resin molded article are further improved. When the content of the thermoplastic resin is below the upper limit, the antiviral properties are further improved.
[0104] The content of the antiviral agent in 100% by weight of the resin molded article is preferably 0.1% by weight or more, more preferably 0.5% by weight or more, even more preferably 0.8% by weight or more, particularly preferably 1% by weight or more, and is preferably 10% by weight or less, more preferably 5% by weight or less, even more preferably 2.5% by weight or less, particularly preferably 1.5% by weight or less, and most preferably 1% by weight or less. When the content of the antiviral agent is at least the above lower limit, the antiviral properties of the resin molded article are further improved. When the content of the antiviral agent is at most the above upper limit, the moldability and mechanical properties are further improved.
[0105] The content of the hydrophilic compound in 100% by weight of the resin molded article is preferably 0.1% by weight or more, more preferably 0.5% by weight or more, even more preferably 1% by weight or more, particularly preferably 2% by weight or more, and most preferably 5% by weight or more, and is preferably 35% by weight or less, more preferably 25% by weight or less, even more preferably 15% by weight or less, and particularly preferably 10% by weight or less. When the content of the hydrophilic compound is above the lower limit, the antiviral properties of the resin molded article become even better. When the content of the hydrophilic compound is below the upper limit, the moldability and mechanical properties become even better.
[0106] In 100% by weight of the resin molded article, the total content of the antiviral agent and the hydrophilic compound is preferably 0.2% by weight or more, more preferably 0.8% by weight or more, even more preferably 1.5% by weight or more, particularly preferably 3% by weight or more, and is preferably 50% by weight or less, more preferably 30% by weight or less, even more preferably 20% by weight or less, particularly preferably 11% by weight or less. When the total content of the antiviral agent and the hydrophilic compound is equal to or greater than the lower limit, the antiviral properties of the resin molded article are further improved. When the total content of the antiviral agent and the hydrophilic compound is equal to or less than the upper limit, the moldability and mechanical properties are further improved.
[0107] In the resin molded article, the weight ratio of the content of the antiviral agent to the content of the hydrophilic compound is referred to as the weight ratio (antiviral agent content / hydrophilic compound content). The weight ratio (antiviral agent content / hydrophilic compound content) is preferably 0.1 or more, more preferably 0.15 or more, even more preferably 0.20 or more, particularly preferably 0.25 or more, and is preferably 10 or less, more preferably 5 or less, even more preferably 1.0 or less, even more preferably 0.8 or less, particularly preferably 0.5 or less, and most preferably 0.4 or less. When the weight ratio (antiviral agent content / hydrophilic compound content) is equal to or greater than the lower limit and equal to or less than the upper limit, the antiviral properties of the resin molded article are further improved.
[0108] The total content of the thermoplastic resin, the antiviral agent, and the hydrophilic compound in 100% by weight of the resin molded article is preferably 50% by weight or more, more preferably 70% by weight or more, even more preferably 80% by weight or more, and particularly preferably 90% by weight or more. The total content of the thermoplastic resin, the antiviral agent, and the hydrophilic compound in 100% by weight of the resin molded article may be 100% by weight, 100% by weight or less, or less than 100% by weight. When the total content of the thermoplastic resin, the antiviral agent, and the hydrophilic compound is equal to or greater than the lower limit, the antiviral properties of the resin molded article are further improved.
[0109] [Other Details of Resin Material] The resin material may be a molding resin material or a resin material different from the molding resin material. The resin material may be a coating resin material or a resin material different from the coating resin material. The resin material may be a coating material or a resin material different from the coating material.
[0110] Methods for molding the resin material include press processing, extrusion processing, extrusion lamination processing, injection molding, etc. The resin material is preferably molded by injection molding.
[0111] The above resin material is particularly preferably an injection molding material because it has excellent moldability.
[0112] The resin material is preferably in the form of resin pellets, which have excellent moldability, and can be melted and molded to obtain a resin molded product with excellent antiviral properties.
[0113] The shape of the resin pellets is not particularly limited, and examples include spherical, cylindrical, and prismatic shapes. From the viewpoint of pellet shape stability, a cylindrical shape is preferred. The maximum length dimension of the resin pellets is preferably 1 mm or more, more preferably 3 mm or more, and preferably 10 mm or less, more preferably 7 mm or less. The size of the resin pellets (such as the maximum length dimension) can be measured using a vernier caliper. It is preferred to randomly sample 100 resin pellets and measure their size.
[0114] When the resin pellets have a cylindrical shape, for example, the resin pellets preferably have the following sizes: The diameter of the resin pellets is preferably 0.5 mm or more, more preferably 1 mm or more, and preferably 5 mm or less, more preferably 3 mm or less. The length of the resin pellets is preferably 1 mm or more, more preferably 3 mm or more, and preferably 10 mm or less, more preferably 7 mm or less.
[0115] The resin material is preferably a masterbatch. The resin material can also be provided as a masterbatch having excellent antiviral properties. The resin material (masterbatch) can be used by mixing with another resin material (a resin material different from the resin material according to the present invention). The masterbatch may be a resin pellet. The other resin material may be a resin pellet. The resin material (masterbatch) and the other resin material are mixed to obtain a mixed resin material, and then the mixed resin material is molded to obtain a molded product having excellent antiviral properties.
[0116] It is preferable that the composition of the resin material is different from the composition of the other resin material. The thermoplastic resin in the resin material and the thermoplastic resin in the other resin material may be the same or different. The other resin material may or may not contain the thermoplastic resin contained in the resin material of the present invention. The other resin material preferably contains a polyolefin resin, an acrylonitrile-butadiene-styrene resin, or a polyvinyl chloride resin, and more preferably contains a polyolefin resin. The other resin material may or may not contain the antiviral agent contained in the resin material of the present invention. The other resin material may or may not contain an antiviral agent. The other resin material may or may not contain the hydrophilic compound contained in the resin material of the present invention. The other resin material may or may not contain a compound that is different from the antiviral agent and has a hydrophilic group.
[0117] When the resin material (masterbatch) is mixed with another resin material to obtain a mixed resin material, it is preferable that the following blending ratio be satisfied: The content of the resin material (masterbatch) in 100% by weight of the mixed resin material is preferably 0.1% by weight or more, more preferably 1% by weight or more, even more preferably 5% by weight or more, particularly preferably 10% by weight or more, and is preferably 99.9% by weight or less, more preferably 99% by weight or less, even more preferably 50% by weight or less, particularly preferably 40% by weight or less.
[0118] [Method for manufacturing a resin molded product] The method for manufacturing a resin molded product according to the present invention includes a molding step of molding the resin material to obtain a resin molded product. Because the resin material has excellent moldability, it is preferable to obtain the resin molded product by injection molding.
[0119] The method for producing a resin molded product according to the present invention may include a mixing step of mixing the antiviral resin material with another resin material to obtain a mixed resin material containing the antiviral resin material and the other resin material. In this case, the mixed resin material is molded in the molding step. Because this method has excellent moldability, it is preferable to injection mold the mixed resin material in the molding step.
[0120] [Other Details of Resin Molded Article] An example of a resin molded article according to the present invention will be described with reference to Fig. 1. Fig. 1 is a cross-sectional view that schematically shows a resin molded article according to one embodiment of the present invention.
[0121] The resin molded article 10 shown in FIG. 1 has antiviral properties. The resin molded article 10 includes a resin part 1 and an antiviral agent 2. The resin part 1 contains the above-described thermoplastic resin. The resin part 1 preferably contains the above-described hydrophilic compound. In the resin molded article 10, the antiviral agent 2 is disposed inside the resin part 1. The antiviral agent 2 may be exposed from the outer surface of the resin part 1. The contact angle of the surface of the resin molded article 10 with water at 23°C is preferably equal to or less than the above-described upper limit.
[0122] Like the resin molded product 10, the resin molded product preferably includes a resin portion and an antiviral agent.
[0123] Examples of molding methods for obtaining the resin molded article include press processing, extrusion processing, extrusion lamination processing, injection molding, etc. The resin molded article is preferably an injection molded article.
[0124] The resin molded article may be a stretched article, or may be used after being stretched. The resin molded article may also be a secondary molded article that has been stretched.
[0125] The shape of the injection-molded article is not particularly limited. The injection-molded article may be in a sheet shape or a shape other than a sheet shape. In this specification, a film is included in the term "sheet."
[0126] The maximum length dimension of the resin molded article is preferably 1 μm or more, more preferably 3 μm or more, even more preferably 5 μm or more, and particularly preferably 10 μm or more. The maximum length dimension of the resin molded article may be 100 μm or more, 1 mm or more, 1 cm or more, 10 cm or more, or even 1 m or more. The maximum length dimension of the resin molded article may be 100 m or less, 10 m or less, 2 m or less, or 1.5 m or less. The average thickness of the resin molded article is preferably 0.1 μm or more, more preferably 3 μm or more, even more preferably 5 μm or more, and particularly preferably 10 μm or more. The average thickness of the resin molded article may be 100 μm or more, or may be 1 mm or more. The average thickness of the resin molded article may be 1 m or less, 10 cm or less, 1 cm or less, or 8 mm or less.
[0127] The resin molded products are suitable for use, for example, in interior and exterior materials, toilets, and food preparation areas of transport vehicles such as railway cars, aircraft, ships, and automobiles; interior and exterior materials, toilets, and food preparation areas of buildings; ticket vending machines in train stations; information terminals in commercial facilities; medical equipment in hospitals, etc.
[0128] The present invention will be specifically described below with reference to examples, but the present invention is not limited to the following examples.
[0129] The following materials were prepared:
[0130] (Thermoplastic resin) Polypropylene ("PP" in the table, "Novatec PP BC6C" manufactured by Japan Polypropylene Corporation) Polyethylene ("PE" in the table, "Nipolonhard 1000" manufactured by Tosoh Corporation) ABS resin ("ABS" in the table, "Denka ABS QF" manufactured by Denka Company Limited)
[0131] (Antiviral agents) Sulfonic acid antiviral agents ("Sulfonic acid" in the table, antiviral agent in which a sulfonic acid surfactant is carried on organic particles (polystyrene resin particles), average particle size 5.0 μm) Silver antiviral agents ("Silver" in the table, silver-based inorganic compound particles, average particle size 2.5 μm) Carboxylic acid antiviral agent 1 ("Carboxylic acid 1" in the table, isophthalic acid particles, average particle size 7.0 μm) Carboxylic acid antiviral agent 2 ("Carboxylic acid 2" in the table, terephthalic acid particles, average particle size 7.0 μm) Carboxylic acid antiviral agent 3 ("Carboxylic acid 3" in the table, 1,3-diaminopropanetetraacetic acid particles, average particle size 7.0 μm)
[0132] (Hydrophilic compounds) Polyvinylpyrrolidone ("PVP" in the table, "K30" manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) Polyethylene glycol compound 1 ("PEG1" in the table, polyethylene glycol distearate) Polyethylene glycol compound 2 ("PEG2" in the table, polyethylene glycol monostearate) Polyethylene glycol compound 3 ("PEG3" in the table, polyethylene glycol)
[0133] (Examples 1 to 11 and Comparative Examples 1 to 3) Other resin pellets (base resin materials) were prepared containing the components shown in the following Tables 1 to 4. In addition, the components shown in the following Tables 1 to 4 were blended in the blending amounts shown in the following Tables 1 to 4 to obtain resin pellets (master batches / resin materials).
[0134] The obtained resin pellets (master batch) and the obtained other resin pellets (base resin material) were kneaded at 180°C for 3 minutes using a Labo Plastomill ("KF-100" manufactured by Toyo Seiki Seisakusho, Ltd.) and press-molded to obtain a sheet-shaped resin molded product (average thickness 1 mm). The resin pellets (master batch) and the other resin pellets (base resin material) were used in a ratio such that the blending amounts of each component in the resin molded product were as shown in Tables 1 to 4 below.
[0135] (Evaluation) (1) Contact angle of the surface of a resin molded article The contact angle of the surface of the obtained resin molded article with water at 23°C was measured by the method described above. The contact angle meter used was a "Solid-liquid interface analysis system DropMaster DMs-401" manufactured by Kyowa Interface Science Co., Ltd.
[0136] (2) Antiviral Activity Influenza virus was inoculated into MDCK cells cultured in a 10 cm dish and cultured at 37°C for 1 hour. After culture, the culture supernatant containing the unsensitized virus was removed. Fresh DMEM medium was added to the 10 cm dish from which the supernatant had been removed, and the cells were cultured at 37°C for 4 days. After culture, the culture supernatant was collected and centrifuged at 800 rpm for 5 minutes. The supernatant after centrifugation was used as the virus solution.
[0137] The resulting resin molded article was cut into a 5 cm x 5 cm sample to serve as a test sample. This test sample was placed in a petri dish, and 0.4 ml of a virus solution diluted 10-fold with sterile water was dropped onto the surface of the test sample. The sample was then covered with a cover film, the dish was capped, and the test sample was allowed to stand at 25°C for 24 hours. Next, the virus solution was recovered from the test sample using 10 ml of SCLDP and serially diluted 10-fold with cell maintenance medium. The diluted virus solution was inoculated into MDCK cells cultured in a 6-well plate, and the number of plaques was counted and the antiviral activity value was determined in accordance with ISO 21702. The test was performed on two 6-well plates, and the average antiviral activity value was calculated. Antiviral activity was evaluated according to the following criteria.
[0138] [Criteria for assessing antiviral activity] ○: Antiviral activity value is 3.0 or more △: Antiviral activity value is 2.0 or more and less than 3.0 ×: Antiviral activity value is less than 2.0
[0139] (3) Water Resistance The obtained resin molded article was cut into a size of 5 cm length x 5 cm width, and the resin molded article was immersed in water at 23°C for 18 hours in accordance with SIAA Water Resistance Test Category 1. The resin molded article after immersion was used as a test sample. Except for using this test sample, the average value of the antiviral activity value was calculated in the same manner as in (2) Evaluation of antiviral property above.
[0140] (4) Solvent Resistance The obtained resin molded article was cut into a size of 5 cm length x 5 cm width, and the surface of the resin molded article was wiped 3,650 times with a wiping member impregnated with ethanol. The resin molded article after wiping was used as a test sample. Except for using this test sample, the average value of the antiviral activity value was calculated in the same manner as in (2) Evaluation of antiviral property above.
[0141] (5) Alkali Resistance The obtained resin molded article was cut into a size of 5 cm length x 5 cm width, and the surface of the resin molded article was wiped 3,650 times with a wiping member impregnated with sodium hypochlorite solution. The resin molded article after wiping was used as a test sample. Except for using this test sample, the average value of the antiviral activity value was calculated in the same manner as in (2) Evaluation of antiviral property above.
[0142] The composition of the resin molded products and the evaluation results are shown in the following Tables 1 to 4. In the tables, "-" indicates that no compound was added.
[0143]
[0144]
[0145]
[0146]
[0147] Regarding the evaluation results of the above (3) water resistance, the above (4) solvent resistance, and the above (5) alkali resistance, the resin molded articles of Examples 1 to 11 maintained high antiviral activity values after wiping, and had high antiviral properties even after wiping.
[0148] 1... Resin part 2... Antiviral agent 10... Resin molded article (antiviral resin molded article)
Claims
1. The antiviral agent comprises a thermoplastic resin, an antiviral agent, and a compound different from the antiviral agent and having a hydrophilic group, the thermoplastic resin includes a polyolefin resin, an acrylonitrile butadiene styrene resin, or a polyvinyl chloride resin; The antiviral agent comprises a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent.
2. 2. The antiviral resin material according to claim 1, wherein a content of the compound different from the antiviral agent and having a hydrophilic group is 1 wt % or more and 50 wt % or less, based on 100 wt % of the antiviral resin material.
3. 3. The antiviral resin material according to claim 1, wherein a content of the antiviral agent is 0.5% by weight or more and 10% by weight or less, based on 100% by weight of the antiviral resin material.
4. The anti-viral resin material according to claim 1 or 2, wherein the thermoplastic resin comprises the polyolefin resin.
5. The antiviral resin material according to claim 1 or 2, wherein the antiviral agent comprises the sulfonic acid-based antiviral agent.
6. The antiviral resin material according to claim 1 or 2, wherein the compound different from the antiviral agent and having a hydrophilic group includes a polyethylene glycol-based compound, cellulose, or polyvinylpyrrolidone.
7. The antiviral resin material according to claim 1 or 2, which is a resin pellet.
8. The antiviral resin material according to claim 1 or 2, which is a masterbatch.
9. The antiviral resin material according to claim 1 or 2, which is a material for injection molding.
10. A method for producing an antiviral resin molded product, comprising: a molding step of molding the antiviral resin material according to claim 1 or 2 to obtain an antiviral resin molded product.
11. a mixing step of mixing the antiviral resin material with another resin material to obtain a mixed resin material containing the antiviral resin material and the other resin material, The method for producing an antiviral resin molded product according to claim 10 , wherein the mixed resin material is molded in the molding step.
12. The antiviral agent comprises a thermoplastic resin, an antiviral agent, and a compound different from the antiviral agent and having a hydrophilic group, the thermoplastic resin includes a polyolefin resin, an acrylonitrile butadiene styrene resin, or a polyvinyl chloride resin; The antiviral agent comprises a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent.
13. Contains a thermoplastic resin and an antiviral agent, the thermoplastic resin includes a polyolefin resin, an acrylonitrile butadiene styrene resin, or a polyvinyl chloride resin; the antiviral agent comprises a sulfonic acid-based antiviral agent, a silver-based antiviral agent, or a carboxylic acid-based antiviral agent; An antiviral resin molded product, wherein the contact angle of the surface of the antiviral resin molded product with water at 23°C is 89° or less.
14. 13. The antiviral resin molded product according to claim 12, wherein a content of the compound different from the antiviral agent and having a hydrophilic group is 1 weight % or more and 25 weight % or less in 100 weight % of the antiviral resin molded product.
15. The antiviral resin molded product according to any one of claims 12 to 14, wherein a content of the antiviral agent is 0.5% by weight or more and 5% by weight or less, based on 100% by weight of the antiviral resin molded product.
